Concomitant loss of dynorphin, NARP, and orexin in narcolepsy

A Crocker1, R A España, M Papadopoulou

  • 1Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Neurology
|October 26, 2005
PubMed
Abstract

Insights

Narcolepsy with cataplexy involves the loss of orexin-producing neurons. This study found that markers like prodynorphin and neuronal activity-regulated pentraxin (NARP) are also significantly reduced in narcolepsy patients.

Area of Science:

  • Neuroscience
  • Sleep Medicine

Background:

  • Narcolepsy with cataplexy is linked to orexin/hypocretin deficiency.
  • The exact cause is debated, with theories including autoimmune destruction or functional failure of orexin neurons.

Purpose of the Study:

  • To investigate the loss of other orexin neuron markers in narcolepsy with cataplexy.
  • To determine if neuronal activity-regulated pentraxin (NARP) and prodynorphin are affected.

Main Methods:

  • Immunohistochemistry and in situ hybridization were employed.
  • Hypothalami from control and narcolepsy patients were analyzed for orexin, NARP, and prodynorphin expression.

Main Results:

  • In controls, over 80% of orexin neurons expressed prodynorphin mRNA and NARP.
  • Narcolepsy patients showed a drastic reduction, with only 5-10% of normal levels for these markers.

Conclusions:

  • The findings strongly suggest a loss of orexin-producing neurons in narcolepsy with cataplexy.
  • Reduced dynorphin and NARP may also play a role in narcolepsy symptoms.

Related Concept Videos

Sleep-Wake Cycles01:24

Sleep-Wake Cycles

Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and  rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Narcolepsy01:07

Narcolepsy

Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...